Predict your next investment

HEALTHCARE | Biotechnology
imgenex.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Imgenex

Imgenex develops and commercializes reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases. These reagents include antibodies, gene and protein expression systems, and arrays of various cells and tissues for use in studies of functional genomics. Areas of biological interest at Imgenex include cancer, apoptosis (programmed cell death), molecular signaling pathways, cellular aging, and metabolic and infectious diseases.

Imgenex Headquarter Location

11175 Flintkoote Ave Suite E

San Diego, California, 92121,

United States

858-642-0978

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Imgenex

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Imgenex is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.